Nonselective beta-blocker use is associated with increased hepatic encephalopathy-related readmissions in cirrhosis

Figure 1 Cumulative incidence of death or liver transplant in cirrhotic patients with a hepatic encephalopathy-related admission that received nonselective beta-blockers vs those who did not (A) and cumulative incidence of the first hepatic encephalopathy-related readmissions in the same groups after adjusting for competing risk of death or liver transplant (B). HE: Hepatic encephalopathy; LT: Liver transplant; NSBB: Nonselective beta-blocker.